Search | IOVS | ARVO Journals

Showing 1 – 20 of 30

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2025

North Carolina Macular Dystrophy, Haplotype analysis of 37 families shows single founders for each mutation

Kent W Small; Arpier Haritoonian; Jessica Avetisjan; Fadi Shaya; Uma Udar; Nitin Udar; Monique J Leys; Thomas A. Rice; Richard Alan Lewis; Bernard Puech; Elise Heon; Paul S Bernstein; Gregory T. Rognon; Adrienne Scott; Todd Schneiderman; David Wilson; Klaus Rohrschneider; Steven Agemy; Daniel Kiernan; Peter Charbel Issa; Johannes Birtel; Amber Diaz

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):6042.

ARVO Annual Meeting Abstract June 2025

ClinGen X-linked Inherited Retinal Disease Variant Curation Expert Panel (XLIRD VCEP): Modified ACMG Criteria and Variant Curation Progress for RPGR, RS1, CHM, CACNA1F, and RP2

Kim Carlyle Worley; Ma'ayan Mero; William Hankey; Hafiz Muhammad Jafar Hussain; Sabika Firasat; Kristy Lee; Radha Ayyagari; Matthew Benson; Paul A Sieving; Sarah Hull; Christina Zeitz; Richard Alan Lewis; Rui Chen

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):2731.

ARVO Annual Meeting Abstract June 2024

RNA Polymerase II Associated Protein 3 ( RPAP3 ), a novel candidate gene for normal-tension glaucoma

William Presley; Sarah Garnai; Bin Guan; Sayoko E Moroi; Natalie Michaels; Bridget Blevins; Brenda Bohnsack; Jill A Rosenfeld; Richard A Lewis; Lindsay Burrage; Shamika Ketkar; Seong H Jeong; Robert Hufnagel; Julia E Richards; Joshua D Stein; Lev Prasov

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4245.

ARVO Annual Meeting Abstract June 2024

ClinGen X-linked Inherited Retinal Disease Variant Curation Expert Panel (XLIRD VCEP): RPGR Curation Progress, and Initial modified ACMG criteria for RS1 and CHM

Kim Carlyle Worley; Ma'ayan Mero; William Hankey; Lonneke Haer-Wigman; Hafiz Muhammad Jafar Hussain; Kristy Lee; Paul A Sieving; Lori S Sullivan; Christina Zeitz; Richard A Lewis; Rui Chen

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):453.

ARVO Annual Meeting Abstract June 2021

Biocompatibility and Feasibility of VisiPlate, a Novel Ultrathin, Multichannel Glaucoma Drainage Device

Brandon W. Kao; Elana Meer; Thomas A. Barbolt; Richard A. Lewis; Iqbal Ike K. Ahmed; Vivian Lee; Samuel M. Nicaise; Georgia Griggs; Eydie G Miller-Ellis

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3438.

ARVO Annual Meeting Abstract June 2020

North Carolina Macular Dystrophy (NCMD/MCDR1): Haplotype analysis shows single ancestral founder in 13 American families

Kent W Small; Edwin M Stone; Monique J Leys; Richard Alan Lewis; Steven Agemy; Charles A Garcia; Todd Schneiderman; Thomas A Rice; Fadi Shaya

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4462.

ARVO Annual Meeting Abstract July 2018

Long-term Safety and Ocular Hypotensive Efficacy of Netarsudil Ophthalmic Solution: The ROCKET-2 Study

Janet B Serle; Malik Kahook; Richard A Lewis; Theresa G. H. Heah; Nancy Ramirez-Davis; Casey Kopczynski; Dale W Usner; Gary Novack

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1242.

ARVO Annual Meeting Abstract June 2017

3-month Interim Report of a Prospective 12-month Safety and Efficacy Study of Topical PG324 (Fixed Combination of Netarsudil 0.02% and Latanoprost 0.005%) Compared to the Individual Components in Subjects with Elevated Intraocular Pressure

Janet B Serle; Richard Alan Lewis; Casey Kopczynski; Theresa Heah

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2462.

ARVO Annual Meeting Abstract June 2017

North Carolina macular dystrophy: mutations found in 12 additional families

Kent W Small; Fadi Shaya; Svetlana Yelchits; Adam P DeLuca; Richard Alan Lewis; Monique J Leys; Nitin Udar; Benjamin Bakall; Klaus Rohrschneider; Bernard Puech; Virginie Puech; Elise Heon; James C Folk; Gerald A Fishman; Christine Garabetian; Edwin M Stone

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2779.

ARVO Annual Meeting Abstract September 2016

Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 12-Month Interim Results From a Phase 1/2 Clinical Trial

Shamira Perera; Richard A. Lewis; William C Christie; Douglas G Day; E R Craven; Marina Bejanian; Susan S Lee; Margot L Goodkin; Jane Zhang; Michael R Robinson

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12)

ARVO Annual Meeting Abstract September 2016

North Carolina Macular Dystrophy (NCMD / MCDR1) mutations found; PRDM13

Kent W Small; Adam P DeLuca; Frans P Cremers; Carl Hoyng; Monique J Leys; Benjamin Bakall; Richard Allen Lewis; Rosemary Silva-Garcia; Klaus Rohrschneider; Edwin M Stone

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3133.

ARVO Annual Meeting Abstract June 2015

Undiagnosed retinal disease cases caused by mutations in non-canonical retinal disease genes

Xia Wang; Yanming A Feng; Richard A Lewis; Victor Zhang; Jing Wang; Lee-Jun Wong

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2879.

ARVO Annual Meeting Abstract June 2015

Advancing ENV515 (travoprost) Intracameral Implant into Clinical Development: Nonclinical Evaluation of ENV515 in Support of First-Time-in-Human Phase 2a Clinical Study

Tomas Navratil; Andres Garcia; Rozemarijn S Verhoeven; Leo Trevino; Brian C Gilger; Steven L Mansberger; Donald L Budenz; Iqbal Ike K. Ahmed; Richard A. Lewis; Benjamin R Yerxa

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5706.

Genetics November 2014

A Dominant Mutation in Hexokinase 1 ( HK1 ) Causes Retinitis Pigmentosa

PDF

Lori S. Sullivan; Daniel C. Koboldt; Sara J. Bowne; Steven Lang; Susan H. Blanton; Elizabeth Cadena; Cheryl E. Avery; Richard A. Lewis; Kaylie Webb-Jones; Dianna H. Wheaton; David G. Birch; Razck Coussa; Huanan Ren; Irma Lopez; Christina Chakarova; Robert K. Koenekoop; Charles A. Garcia; Robert S. Fulton; Richard K. Wilson; George M. Weinstock; Stephen P. Daiger
TAGS: genes, hexokinase, mutation, retinitis pigmentosa, family
Invest. Ophthalmol. Vis. Sci.. 2014; 55(11):7147-7158. https://doi.org/10.1167/iovs.14-15419

Includes: Supplemental Content

Genetics October 2014

Dependable and Efficient Clinical Utility of Target Capture-Based Deep Sequencing in Molecular Diagnosis of Retinitis Pigmentosa

PDF

Jing Wang; Victor W. Zhang; Yanming Feng; Xia Tian; Fang-Yuan Li; Cavatina Truong; Guoli Wang; Pei-Wen Chiang; Richard A. Lewis; Lee-Jun C. Wong
TAGS: genes, massively-parallel genome sequencing, molecular diagnostic techniques, mutation, retinitis pigmentosa
Invest. Ophthalmol. Vis. Sci.. 2014; 55(10):6213-6223. https://doi.org/10.1167/iovs.14-14936

Includes: Supplemental Content

ARVO Annual Meeting Abstract April 2014

Preclinical Evaluation of ENV515 (travoprost) Intracameral Implant - Clinical Candidate for Treatment of Glaucoma Targeting Six-Month Duration of Action

Tomas Navratil; Andres Garcia; Janet Tully; Benjamin Maynor; Iqbal Ike K Ahmed; Donald L Budenz; Richard A Lewis; Steven L Mansberger; Brian C Gilger; Benjamin R Yerxa

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3548.

ARVO Annual Meeting Abstract April 2014

Next Generation Approach to Molecular Diagnosis of Ocular Diseases

Lee-Jun C Wong; Victor Zhang; Yanming Feng; Fangyuan Li; Cavatina K Truong; Guoli Wang; Jing Wang; Richard A Lewis

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6392.

ARVO Annual Meeting Abstract April 2014

Screening the DNA of Ocular Albinism Patients for Possible Mutations in GNAI3 (Guanine Nucleotide Binding Protein, Alpha Inhibiting Activity Polypeptide 3 gene)

Alejandra Young; Richard A Lewis; Debora B Farber

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6438.

Genetics February 2013

Mutations in the X-Linked Retinitis Pigmentosa Genes RPGR and RP2 Found in 8.5% of Families with a Provisional Diagnosis of Autosomal Dominant Retinitis Pigmentosa

PDF

Jennifer D. Churchill; Sara J. Bowne; Lori S. Sullivan; Richard Alan Lewis; Dianna K. Wheaton; David G. Birch; Kari E. Branham; John R. Heckenlively; Stephen P. Daiger
TAGS: family, genes, mutation, retinitis pigmentosa, x-linked inheritance, cohort studies
Invest. Ophthalmol. Vis. Sci.. 2013; 54(2):1411-1416. https://doi.org/10.1167/iovs.12-11541

Genetics December 2012

Mutations in RPGR and RP2 Account for 15% of Males with Simplex Retinal Degenerative Disease

PDF

Kari Branham; Mohammad Othman; Matthew Brumm; Athanasios J. Karoukis; Pelin Atmaca-Sonmez; Beverly M. Yashar; Sharon B. Schwartz; Niamh B. Stover; Karmen Trzupek; Dianna Wheaton; Barbara Jennings; Maria Laura Ciccarelli; K. Thiran Jayasundera; Richard A. Lewis; David Birch; Jean Bennett; Paul A. Sieving; Sten Andreasson; Jacque L. Duncan; Gerald A. Fishman; Alessandro Iannaccone; Richard G. Weleber; Samuel G. Jacobson; John R. Heckenlively; Anand Swaroop
TAGS: degenerative disorders, mutation, x-linked inheritance, screening, genes
Invest. Ophthalmol. Vis. Sci.. 2012; 53(13):8232-8237. https://doi.org/10.1167/iovs.12-11025

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

North Carolina Macular Dystrophy, Haplotype analysis of 37 families shows single founders for each mutation

ClinGen X-linked Inherited Retinal Disease Variant Curation Expert Panel (XLIRD VCEP): Modified ACMG Criteria and Variant Curation Progress for RPGR, RS1, CHM, CACNA1F, and RP2

RNA Polymerase II Associated Protein 3 ( RPAP3 ), a novel candidate gene for normal-tension glaucoma

ClinGen X-linked Inherited Retinal Disease Variant Curation Expert Panel (XLIRD VCEP): RPGR Curation Progress, and Initial modified ACMG criteria for RS1 and CHM

Biocompatibility and Feasibility of VisiPlate, a Novel Ultrathin, Multichannel Glaucoma Drainage Device

North Carolina Macular Dystrophy (NCMD/MCDR1): Haplotype analysis shows single ancestral founder in 13 American families

Long-term Safety and Ocular Hypotensive Efficacy of Netarsudil Ophthalmic Solution: The ROCKET-2 Study

3-month Interim Report of a Prospective 12-month Safety and Efficacy Study of Topical PG324 (Fixed Combination of Netarsudil 0.02% and Latanoprost 0.005%) Compared to the Individual Components in Subjects with Elevated Intraocular Pressure

North Carolina macular dystrophy: mutations found in 12 additional families

Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 12-Month Interim Results From a Phase 1/2 Clinical Trial

North Carolina Macular Dystrophy (NCMD / MCDR1) mutations found; PRDM13

Undiagnosed retinal disease cases caused by mutations in non-canonical retinal disease genes

Advancing ENV515 (travoprost) Intracameral Implant into Clinical Development: Nonclinical Evaluation of ENV515 in Support of First-Time-in-Human Phase 2a Clinical Study

A Dominant Mutation in Hexokinase 1 ( HK1 ) Causes Retinitis Pigmentosa

Dependable and Efficient Clinical Utility of Target Capture-Based Deep Sequencing in Molecular Diagnosis of Retinitis Pigmentosa

Preclinical Evaluation of ENV515 (travoprost) Intracameral Implant - Clinical Candidate for Treatment of Glaucoma Targeting Six-Month Duration of Action

Next Generation Approach to Molecular Diagnosis of Ocular Diseases

Screening the DNA of Ocular Albinism Patients for Possible Mutations in GNAI3 (Guanine Nucleotide Binding Protein, Alpha Inhibiting Activity Polypeptide 3 gene)

Mutations in the X-Linked Retinitis Pigmentosa Genes RPGR and RP2 Found in 8.5% of Families with a Provisional Diagnosis of Autosomal Dominant Retinitis Pigmentosa

Mutations in RPGR and RP2 Account for 15% of Males with Simplex Retinal Degenerative Disease

To View More...

You must be signed into an individual account to use this feature.